Home Mission Training Who We Are Venue FAQ Contact Apply Now

Applications open September 1, 2026

Deadline: November 30, 2026

Program: March 2027 · Mexico

IMPACT-AD LATAM

Institute on Methods and Protocols for Advancement of Clinical Trials in Alzheimer's Disease and Related Dementias – Latin America

Strengthening the ADRD clinical trial workforce in Latin America.

IMPACT-AD LATAM is a regional training initiative designed to prepare diverse, implementation-ready investigators to lead high-quality ADRD clinical trials across Latin America.

27M+

people in Latin America are projected to be living with dementia by 2050

Limited access

to training and mentorship is a key barrier to expanding ADRD clinical trial capacity in LatAm


What is IMPACT-AD LATAM?

IMPACT-AD LATAM is designed as a comprehensive and interactive training course for investigators and site personnel across Latin America who are interested in establishing, strengthening, and sustaining clinical trials in Alzheimer's disease and related dementias.

Building on the successful IMPACT-AD model, the curriculum has been adapted to regional needs, with a deliberate emphasis on operational readiness, site-level implementation, and participant-centered trial practices. The course will be delivered as an intensive, in-person program spanning three full days.

Faculty will include international and regional partners with recognized expertise in ADRD science, trial operations, ethics, biostatistics, and clinical research implementation. Instruction will be conducted in both Spanish and English to maximize accessibility and support meaningful participation across the region.

Our Approach

Training

Delivering rigorous, evidence-based training for Principal Investigators and multidisciplinary site teams across Latin America.

Operational Readiness

Strengthening the practical skills needed to implement and run ADRD clinical trials efficiently from day one.

Site Capacity

Building sustainable research infrastructure and operational capacity at participating sites across the region.

Regional Network

Connecting investigators and site teams to grow a collaborative Latin American ADRD clinical trials community.

Applications Open September 1, 2026

Deadline: November 30, 2026 Β· Program: March 2027 Β· Mexico

Apply Now
πŸ“…

Informational webinar on August 5th.

Register here

Our Partners

Our Mission & Vision

Mission

To strengthen the ADRD clinical trial workforce in Latin America by delivering rigorous, bilingual, implementation-focused training that equips investigators and site teams to lead high-quality trials across the region.

Vision

A Latin America where diverse, implementation-ready investigators lead ADRD clinical trials that include and reflect the populations most affected by Alzheimer's disease and related dementias.

Training

3-Day Intensive

In-person program in Mexico, March 2027

Bilingual

Delivered in English and Spanish

Expert Faculty

International and regional ADRD specialists

Curriculum

Key Learning Areas

Key Learning Areas for IMPACT-AD LATAM Curriculum

Frequently Asked Questions

Investigators and site staff across Latin America who are interested in establishing, strengthening, and sustaining clinical trials in Alzheimer's disease and related dementias (ADRD). This includes Principal Investigators, research coordinators, physicians, and multidisciplinary research team members.
The program is scheduled for March 2027 in Mexico. Exact dates and venue details will be announced in advance.
Yes, participants who complete the full program will receive a certificate of completion. Details will be provided to accepted applicants.
The program is bilingualβ€”conducted in both English and Spanish to ensure accessibility for participants across Latin America. However, most courses and materials will be delivered in English, so applicants are expected to have a good level of English proficiency.
There is no registration fee for accepted participants. Travel and accommodation support may be available for selected participants. Details will be provided upon acceptance.
Applications are submitted through ProposalCentral. First-time users must register and complete a Professional Profile before applying. Applications open on September 1, 2026 and close on November 30, 2026. Visit the Apply Now section for full instructions.
Applicants must submit: (1) a Personal/Career Statement describing their goals and research interests; (2) an NIH-style Biosketch, maximum 5 pages; and (3) an Institutional Letter of Support from a representative of their institution.

Contact Us

info@latamimpactad.com